Arcutis Biotherapeutics, Inc. (ARQT)

NMS – Real Time Price. Currency in USD

26.18

-0.05 (-0.19%)

Market open: Aug 12, 2026, 2:10 PM EDT

26.07

-0.16 (-0.61%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

376M

197M

60M

Cost of goods sold

-37M

-19M

-6M

-2M

Gross Profit

339M

177M

53M

Operating expenses (excl. COGS)

-352M

-306M

-295M

-304M

Operating Income

-12M

-128M

-241M

-302M

Non-operating income, total

-3M

-11M

-18M

-10M

Pretax income

-15M

-139M

-259M

-311M

Equity in earnings

Taxes

-1M

-647K

-3M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-16M

-140M

-262M

-311M

Discontinued operations

Net income

-16M

-140M

-262M

-311M

Dilution adjustment

Preferred dividends

Arcutis Biotherapeutics, Inc. (ARQT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arcutis Biotherapeutics, Inc. (ARQT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Arcutis Biotherapeutics, Inc. (ARQT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arcutis Biotherapeutics, Inc. (ARQT)

Income Statement (Annual)

Income Statement (Annual)